1. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer
   Chantel Samardzija et al, 2015, Molecular Cancer CrossRef
2. The oncogenic potential of NANOG: An important cancer induction mediator
   Basira Najafzadeh et al, 2021, Journal of Cellular Physiology CrossRef
3. Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cells
   Yanwen Zhou et al, 2018, Cell Death & Disease CrossRef
4. Reporters of Cancer Stem Cells as a Tool for Drug Discovery
   Amrutha Mohan et al, 2021, Frontiers in Oncology CrossRef
5. The expression of the embryonic gene Cripto‐1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells
   Sung‐Won Park et al, 2018, FEBS Letters CrossRef
6. Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9
   Banu Iskender et al, 2015, Journal of Natural Medicines CrossRef
7. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation
   Seyyed Mehdi Jafari et al, 2018, Cellular Oncology CrossRef
8. Gene of the month: NANOG
   Mireia Mato Prado et al, 2015, Journal of Clinical Pathology CrossRef
9. Hsa-miR-3658 down-regulates OCT4 gene expression followed by suppressing SW480 cell proliferation and migration
   Fahimeh Hosseini et al, 2020, Biochemical Journal CrossRef
10. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells
    Daria Gauck et al, 2017, BMC Cancer CrossRef
11. Evaluating of OCT-4 and NANOG was differentially regulated by a new derivative indole in leukemia cell line
    Mojgan Noroozi Karimabad et al, 2017, Immunology Letters CrossRef
12. Stem cell transcription factor NANOG in cancers – is eternal youth a curse?
    Oscar GW Wong et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
13. DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor–Positive Breast Cancer Following Endocrine Therapy
    Daniel S. Peiffer et al, 2019, Cancer Research CrossRef
14. NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis
    Kotaro Saga et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
15. Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
    Bi Chen et al, 2020, Frontiers in Oncology CrossRef
16. GCNF regulates OCT4 expression through its interactions with nuclear receptor binding elements in NCCIT cells
    Sung‐Won Park et al, 2018, Journal of Cellular Biochemistry CrossRef
17. Effect of Melatonin on Chemoresistance Exhibited by Spheres Derived from Canine Mammary Carcinoma Cells
    Dania Cataldo et al, 2024, Animals CrossRef
18. Targeting Breast Cancer Stem Cells
    Phuc Van Pham, 2015, Breast Cancer Stem Cells & Therapy Resistance CrossRef
19. Polyphenols Extracted from Artemisia annua L. Exhibit Anti-Cancer Effects on Radio-Resistant MDA-MB-231 Human Breast Cancer Cells by Suppressing Stem Cell Phenotype, β-Catenin, and MMP-9
    Young Shin Ko et al, 2020, Molecules CrossRef
20. CD44v6+ Hepatocellular Carcinoma Cells Maintain Stemness Properties through Met/cJun/Nanog Signaling
    Wei Chen et al, 2022, Stem Cells International CrossRef
21. Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells
    Amrutha Mohan et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
22. Alterations of The Stem-Like Properties in The Breast Cancer Cell Line MDA-MB-231 Induced by Single Pulsed Doxorubicin Treatment
    Valdis Pirsko et al, 2019, Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. CrossRef
23. NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
    Sten Friberg et al, 2016, Journal of Nanobiotechnology CrossRef